The Union Ministry of Commerce and Industry in India has initiated an anti-dumping investigation into imports of the antibiotic metronidazole, following a complaint filed by Aarti Drugs Ltd., one of the largest manufacturers of the drug in the country.
Complaint Details
Aarti Drugs alleges that Chinese companies aredumping metronidazole at prices below fair market value, causing significant losses to domestic industries. The company has requested the imposition of anti-dumping duties on imports of metronidazole from China to address these concerns and protect local manufacturers.
About Metronidazole
Metronidazole is a widely used antibiotic for treating bacterial and parasitic infections, including amoebic dysentery, trichomoniasis, and gingivitis. Despite its importance in healthcare, the market has seen intense competition, with over 900 companies securing approvals for metronidazole in China alone, according to Fineline Info & Tech data.
Current Developments
India’s Directorate General of Trade Remedies (DGTR) will now investigate the allegations, examining price trends from 2018-2021. A response is expected within 30 days, marking a critical step in addressing concerns over fair trade practices in the pharmaceutical sector.-Fineline Info & Tech
